Joyce Pagan

Editor https://www.cancertherapyadvisor.com

Joyce Pagan is the editor of Oncology Nurse Advisor, part of the Haymarket Oncology brands. Prior to taking the helm of Oncology Nurse Advisor, Joyce held many roles in medical publishing brands ranging from design, production, and editorial that served various specialties.

All articles by Joyce Pagan

Discussing a treatment regimen with a patient.

Multiple Myeloma

Anticipatory Management, Adherence Strategies Optimize MM Treatment With Selinexor

Joyce Pagan

October 23, 2020

Commonly reported AEs of selinexor include nausea, anorexia, fatigue, thrombocytopenia, and hyponatremia.

ASCO 2020

Palliative Care in Phase 1 Trials is Essential for Patients and Their Caregivers

Joyce Pagan

June 8, 2020

Structured palliative care can ensure these patients and their caregivers have an optimal experience that does not hinder trial outcomes.

ASCO 2020

Pilot Program Shows That Remote Intensive Monitoring in High-Risk Patients May Improve Outpatient Symptom Management

Joyce Pagan

June 4, 2020

Using remote communications technology, a major cancer center was able to manage symptoms in high-risk patients initiating treatment at a regional location.

ASCO 2020

Close Monitoring, Full-Time Caregiver Recommended for 30 Days After CAR-T Therapy

Joyce Pagan

June 3, 2020

Readmissions for CRS, neurotoxicity, infection, and other adverse events are common after immunotherapy with axicabtagene ciloleucel.

Following a smoking smoking cessation program.

ASCO 2020

Does Patient Interest Show a Need for Cessation Programs in Lung Cancer Multidisciplinary Clinics?

Joyce Pagan

June 3, 2020

Researchers surveyed consecutive new patients at a multidisciplinary clinic to determine smokers’ willingness to participate in a cessation program.

General Oncology

Assessing Goals of Care to Ensure End-of-Life Care Follows Patients’ Wishes

Joyce Pagan

March 12, 2020

A single-item visual analog scale has been shown to ensure that oncologists’ perceptions and patients’ wishes for end of life care are in agreement.

General Oncology

Clinical Trial Participation May Not Improve Outcomes in Socioeconomically Deprived Areas

Joyce Pagan

September 20, 2019

Researchers demonstrated the significance of access to supportive and posttrial care as it relates to cancer survival among clinical trial participants.

General Oncology

CMS Increases Reimbursement Rate for Product Cost of CAR-T Therapy

Joyce Pagan

August 8, 2019

Fiscal year 2020 Inpatient Prospective Payment System from CMS includes an increase in the reimbursement rate for CAR-T therapy; however, it falls short of suggestions ASH had submitted to the agency.